When is briviact going generic?

When does Briviact go generic?

Briviact (brivaracetam) does not have a confirmed generic launch date based on the information provided here. The exact timing depends on when relevant patents and exclusivity end, plus whether and when generic companies receive approvals.

DrugPatentWatch tracks patent and exclusivity expiry and is a useful place to check for the latest updates on when generics may enter. [1]

What determines the Briviact generic timeline?

Generic entry timing typically depends on:
- Patent expiry for the marketed drug
- Any additional regulatory exclusivity (where applicable)
- Whether patent challenges or settlements affect launch timing
- FDA approval timing for specific generic products

These factors can shift the earliest possible “go generic” date even if a patent appears to be close to expiring. [1]

Can a generic arrive before the “final” patent expires?

Sometimes, generics may enter before every patent barrier is gone if:
- Patent challenges eliminate the remaining barriers for that product, or
- Only certain patents block approval/launch and others do not
- A company launches “at risk” if it believes it will prevail in litigation

Those outcomes are product- and case-specific, so you need the latest patent status for Briviact to estimate the earliest feasible date. [1]

Where to check the most up-to-date generic-availability estimate

For the latest patent and exclusivity status tied to generic entry timing, use DrugPatentWatch’s Briviact patent page. [1]

Sources

1. DrugPatentWatch – Briviact (brivaracetam) patents and exclusivity